中文
Product Center
Product Center
Process development and optimization of pharmaceutical intermediates and APIs
Process development and optimization of pharmaceutical intermediates and APIs
Isavuconazole
Broad-spectrum triazole antifungal; treatment of invasive mucormycosis and aspergillosis in adults
Fondaparinux Sodium
Anticoagulant drugs for major lower extremity orthopedic surgery to prevent venous thromboembolic events
About Us
·Company news ·Industry news ·Frontline information
Nantong Nuotai Biomedical Technology Co., Ltd. was established in Nantong Haimen Science and Technology Park in March 2015. The company has 60 employees, 20 R&D teams, and 90% of them have bachelor degree or above. The company has always been market-oriented and innovation-driven; it is committed to providing pharmaceutical companies with innovative chemical services throughout the entire industry chain, including: research and development of innovative drugs, process development and optimization of key pharmaceutical intermediates and APIs; high-end pharmaceutical intermediates commercial production and custom synthesis services.
Nuotai will uphold the concept of innovation, devote itself to drug innovation, always insist on enhancing the value of brands, creating differences with innovation, and winning competition with cost to meet the needs of the market. "Core" business philosophy, serve new and old customers at home and abroad, and make Nuotai a trustworthy partner for domestic and foreign customers!
About Us
·Company news ·Industry news ·Frontline information
Nantong Nuotai Biomedical Technology Co., Ltd. was established in Nantong Haimen Science and Technology Park in March 2015. The company has 60 employees, 20 R&D teams, and 90% of them have bachelor degree or above. The company has always been market-oriented and innovation-driven; it is committed to providing pharmaceutical companies with innovative chemical services throughout the entire industry chain, including: research and development of innovative drugs, process development and optimization of key pharmaceutical intermediates and APIs; high-end pharmaceutical intermediates commercial production and custom synthesis services.
Nuotai will uphold the concept of innovation, devote itself to drug innovation, always insist on enhancing the value of brands, creating differences with innovation, and winning competition with cost to meet the needs of the market. "Core" business philosophy, serve new and old customers at home and abroad, and make Nuotai a trustworthy partner for domestic and foreign customers!
Research and production base
In 2019, it will be located in a provincial chemical park in Shandong Province, and will be invested in Jinan, Shandong to establish Shandong Elite Biomedical Technology Co., Ltd.
The workshop construction will be completed in 2020.
In 2021, the trial production will be completed and it will be officially put into production.
Anhydrous, oxygen-free, hydrogenated
High temperature and high pressure, ultra-low temperature
Optimization and commercial production of difficult chemical processes
Research and production base
In 2019, it will be located in a provincial chemical park in Shandong Province, and will be invested in Jinan, Shandong to establish Shandong Elite Biomedical Technology Co., Ltd.
The workshop construction will be completed in 2020.
In 2021, the trial production will be completed and it will be officially put into production.
Anhydrous, oxygen-free, hydrogenated
High temperature and high pressure, ultra-low temperature
Optimization and commercial production of difficult chemical processes
News Center
2020
08 18
2019
08 16
2018
06 24
2017
03 30
Company address: Building B2, Linjiang Biomedical Pioneering Park, Haimen City, Nantong City, Jiangsu Province
Tel: 0513-82206272 17712268337
Email: sinyzhang@noatic.com